Skip to main content
. 2021 Mar 8;16(3):e0247365. doi: 10.1371/journal.pone.0247365

Table 1. Baseline demographic and clinical characteristics of each group.

Group 1 Group 2 Total p-value
Age 50.38 (±11.90) 67.40 (±14.32) 57.33 (±15.34) ***< 0.001b
Sex (male:female) M:12, F:17 (F: 58.6%) M:9, F:11 (F: 55.0%) M:21, F:28 (F: 57.1%) 0.801c
Meibography score 3.24 (±0.79) 5.15 (±0.37) 4.02 (±1.15) ***< 0.001b
OSDI 47.55 (±23.05) 31.95 (±17.94) 41.18 (±22.30) *0.014a
TBUT (seconds) 5.87 (±1.75) 5.88 (±1.32) 5.87 (±1.57) 0.977a
Schirmer’s test (mm) 7.26 (±4.34) 6.78 (±4.76) 7.06 (±4.48) 0.521b
Expressibility of meibum 22.28 (±11.10) 19.80 (±11.99) 21.27 (±11.42) 0.461a
Cornea staining score 1.34 (±0.54) 1.38 (±0.83) 1.36 (±0.66) 0.966b
Meibum quality score 2.12 (±0.42) 2.32 (±0.73) 2.20 (±0.57) 0.063b

Data are presented as number and mean value±standard deviation. Group 1: mild to moderate dropout of the meibomian gland; Group 2: severe dropout of the meibomian gland.

a: Independent samples t-test results.

b: Mann-Whitney U test results.

c: chi-squared (χ2) test result. OSDI: ocular surface disease index; TBUT: tear film break-up time.

* p<0.05,

*** p<0.001.